Soluble IL-17RCx4 and methods of using in inflammation

Details for Australian Patent Application No. 2007300393 (hide)

Owner ZymoGenetics, Inc.

Inventors Levin, Steven D.; Gao, Zeren; Rixon, Mark W.; Kuestner, Rolf E.

Agent Spruson & Ferguson

Pub. Number AU-B-2007300393

PCT Pub. Number WO2008/039553

Priority 60/772,177 10.02.06 US; 60/781,078 10.03.06 US

Filing date 9 February 2007

Wipo publication date 3 April 2008

Acceptance publication date 31 May 2012

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2008/039553 Priority application(s): WO2008/039553

31 May 2012 Application Accepted

  Published as AU-B-2007300393

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300402-Process for solubilization of flavor oils

2007300392-Enhanced oxygenate conversion and product cracking integration